Provided herein are compounds and pharmaceutical compositions comprising said compounds that are useful for treating cancers or congenital diseases. Specific cancers and congenital disease includes those that are mediated by YAP/TAZ.
-
(2017/08/01)
Pyruvate kinase activators for use in therapy
Described herein are methods for using compounds that activate pyruvate kinase.
-
Page/Page column 80
(2016/08/29)
5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
Compounds of Formula (00A) and methods of use as Janus kinase inhibitors are described herein.
-
Paragraph 0746
(2015/12/05)
Aralkyl-ketone piperazine derivatives and their uses as new antalgic or ataractic agent
Arylalkyl ketone piperazine derivatives of the formula: and pharmaceutical compositions comprising the same. Also dislcosed are methods for using the compounds as analgesic and sedative agents. The compounds of the present invention have good analgesic and sedative activities but few side effects.
-
Page/Page column 13
(2008/06/13)
Aralkyl-alcohol peiperazine derivatives adn their uses as antidepressant
Aryl alkanol piperazine derivatives of the formula and pharmaceutical compositions comprising the same. Also disclosed are methods for treating depression using the pharmaceutical compositon. Compounds of the invention have excellent dual inhibitory actions to the uptake of the mono-amines neurotransmitter, good antidepressant activities and minor side effects.
-
Page/Page column 12
(2008/06/13)
More Articles about upstream products of 685105-96-8